Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.16.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.62NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.6.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FK.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.4.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.9.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDBNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GM.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.44NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FU.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GJ.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.22.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FE.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBL.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.56NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.49NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBL.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FR.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.18.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.23.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.21.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.42NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.4.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GR.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.568NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used